Published on:

Safety concerns over diabetes drug rejected

International medical experts publicly rejected product safety concerns over a pharmaceutical group’s diabetes drug Lantus. The researchers called for more detailed analysis sparked by product safety issues raised in four studies published last month.

To read more about the rejected safety concerns.